Edition:
United Kingdom

People: Healios KK (4593.T)

4593.T on Tokyo Stock Exchange

1,473JPY
19 Jul 2019
Change (% chg)

¥-14 (-0.94%)
Prev Close
¥1,487
Open
¥1,491
Day's High
¥1,519
Day's Low
¥1,439
Volume
396,600
Avg. Vol
197,670
52-wk High
¥2,180
52-wk Low
¥1,439

Reaves, Al 

Mr. Al Reaves has been serving as Director of Global Development and Director in Healios K.K. since January 2014. He is also serving as President in OphthaConsult, LLC. He used to work for Alcon Laboratories, Inc., Xenon Vision, Inc., Novartis Ophthalmics, Neurotech USA, Inc., Othera Pharmaceuticals, Inc. and Acucela, Inc.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --